Company Active LTD

Company profile

Cyted Ltd

The Data-Driven Diagnostics Company | Cyted

Our unique approach combines expertise in gastrointestinal oncology, digital pathology and AI-driven biomarker discovery.

CRN
11478299
Founded
2018
Age
7

Overview

Legal name
CYTED LTD
Region
East of England
Registered address
GROUND FLOOR BUILDING 3 OLD SWISS
149 CHERRY HINTON ROAD
CAMBRIDGE
UNITED KINGDOM
CB1 7BX
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

6 levels 4 ultimate controllers Controls 1
1
Company Active LTD
Cyted Ltd
CRN 11478299
2
Direct controller Active LTD
3
Intermediate controller Active PLC
BGF Group PLC
CRN 10657226
4
Intermediate controller Active LTD
5
Intermediate controller Active LTD
6
Intermediate controller Active LTD
7
Intermediate controller Active LTD
8
Intermediate controller Active PLC
HSBC Bank PLC
CRN 00014259
9
Intermediate controller Active LTD
10
Intermediate controller Active LTD
11
Intermediate controller Active LTD
12
Ultimate controller Active PLC
HSBC Holdings PLC
CRN 00617987
13
Intermediate controller Active LTD
14
Ultimate controller Active PLC
Natwest Group PLC
CRN SC045551
15
Ultimate controller Active PLC
16
Ultimate controller Active PLC
Barclays PLC
CRN 00048839

Company events

Reference milestones and recent Companies House filing stream events.

11 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

05 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

25 Mar
2026

Legacy

Miscellaneous

RP01SH01 | Transaction MzUwODQyMzU0OGFkaXF6a2N4

Published 25 Mar 2026 12:25

25 Nov
2025

Capital Allotment Shares

Capital

SH01 | Transaction MzQ5MDgxOTk4M2FkaXF6a2N4 | Paper/PDF filed

Published 25 Mar 2026 12:25

22 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

25 Aug
2024

Accounts With Accounts Type Group

Accounts PDF pending

AA | Transaction MzQzMjY0Njk4OGFkaXF6a2N4 | Paper/PDF filed

Published 26 Aug 2024 06:37

20 Aug
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzMjcyMzI1NWFkaXF6a2N4

Published 20 Aug 2024 09:23

16 Aug
2024

Capital Name Of Class Of Shares

Capital

SH08 | Transaction MzQzMTk3MzQ0MWFkaXF6a2N4 | Paper/PDF filed

Published 17 Aug 2024 07:54

15 Aug
2024

Capital Variation Of Rights Attached To Shares

Capital

SH10 | Transaction MzQzMTk3MzU1N2FkaXF6a2N4 | Paper/PDF filed

Published 16 Aug 2024 12:40

23 Jul
2018

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020, 2024
Age at first award
1 years

Projects

2024 Collaborative R&D Lead participant

QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis

1 Jan 2024 to 30 Jun 2025

Awarded
£398,284
Total cost £663,806

Eosinophilic oesophagitis (EoE) is a disease of the oesophagus ("food pipe") affecting tens of thousands of adults and children across the UK. Related to asthma, allergies and other chronic inflammatory conditions, this disease has been on the rise in the last decade. However, it can often take years and even several trips to A&E due to food getting stuck...

2020 Collaborative R&D

Project DELTA - integrateD diagnostic solution for EarLy deTection of oesophageal cAncer

1 Feb 2020 to 30 Apr 2023

Awarded
£1,062,858
Total cost £1,518,369

N/A

Product types

Collaborative R&D